Stock Investors Bid Up Shares of Optimer Pharmaceuticals, Up 3.3% – Financial News Network Online

Optimer Pharmaceuticals, Inc. discovers, develops, and commercializes anti infective products. Optimer’s initial development efforts address products that treat gastrointestinal infections (GI), and related diseases, including diminished efficacy …